Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 06, 2025 (GLOBE NEWSWI ...

文章核心观点 - 公司通过旗舰设备NexWave提供无创、非成瘾性的家庭疼痛管理方案，以应对阿片类药物危机，销售副总裁阐述公司使命、产品特点及发展愿景 [1] 公司情况 - 销售副总裁Steve Fox有近20年销售和运营经验，涉足多个领域，因公司文化、使命和增长潜力加入 [3][4] - 公司核心是无创、非阿片类疼痛管理，约300名销售代表在美国向医疗服务提供者宣传家庭疼痛管理替代方案 [5] 产品情况 - 旗舰产品NexWave是三合一设备，包含TENS、IFC和NMES功能，适用于康复和疼痛管理，受医疗服务提供者欢迎 [6] 发展愿景 - 销售副总裁的工作是延续并扩大公司的增长，让更多医疗服务提供者了解公司，使公司家喻户晓 [7] - 目前公司主要聚焦美国市场，销售代表注重对医疗服务提供者的教育 [8] 公司文化 - 公司使命是提供家庭、无创、非成瘾性疼痛管理方案，这驱动着公司发展，所有销售代表都认同该使命 [9] 市场契合度 - 随着人口老龄化，更多人避免手术且需非阿片类疼痛管理方案，公司产品无创、非成瘾、易用，受老年群体欢迎 [10]

文章核心观点 Levi & Korsinsky, LLP 通知 Zynex, Inc. 投资者有关该公司的证券集体诉讼，指控被告证券欺诈，投资者可在规定时间申请成为首席原告，律所经验丰富 [1][2][3] 案件详情 - 被告虚假陈述或隐瞒公司产品发货超需求、虚增收入、虚假索赔遭保险公司审查、可能面临不利后果及相关积极陈述误导等情况 [2] 后续安排 - 相关时间段内受损的投资者需在 2025 年 5 月 19 日前申请成为首席原告，不担任首席原告也可参与赔偿分配 [3] 律所优势 - 过去 20 年为股东争取数亿美元赔偿，擅长复杂证券诉讼，有超 70 名员工，连续 7 年跻身美国证券诉讼律所前 50 [4] 联系方式 - 律所信息：Levi & Korsinsky, LLP，地址为 33 Whitehall Street, 17th Floor, New York, NY 10004，邮箱 [email protected]，电话 (212) 363 - 7500，传真 (212) 363 - 7171，网址 www.zlk.com [5] - 投资者可通过链接 https://zlk.com/pslra - 1/zynex - inc - lawsuit - submission - form?prid = 140697&wire = 4 获取信息，也可联系 Joseph E. Levi, Esq.，邮箱 [email protected]，电话 (212) 363 - 7500 [1]

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the “Class Period”), of the important May 19, 2025 lead plaintiff deadline. SO WHAT: If you purchased Zynex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=140443&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

NEW YORK, April 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=140408&from=4CLASS PERIOD: March 13, 2023 to March 11, 202 ...

文章核心观点 因Zynex公司2024年第四季度和全年财务业绩不佳致股价下跌，投资者发起证券集体诉讼，诉讼聚焦公司销售、计费、收入确认等方面的不当陈述及与军方医疗计划的关系 [1][2] 分组1：诉讼基本信息 - 诉讼已针对医疗设备制造商Zynex公司提起，旨在代表2023年3月13日至2025年3月11日期间购买该公司证券的投资者 [1] - 诉讼案号为Tuncel v. Zynex, Inc., et al., No. 1:25 - cv - 00913 (D. Colo.) [1] - 集体诉讼期间为2023年3月13日至2025年3月11日，首席原告截止日期为2025年5月19日 [2] - 投资者可访问www.hbsslaw.com/investor - fraud/zyxi，或联系[email protected]、拨打844 - 916 - 0895提交损失 [2] 分组2：公司财务情况 - 2025年3月12日，因2024年第四季度和全年财务业绩不佳，Zynex股价下跌3.59美元（-51%） [1] - 2024年第四季度收入较上年同期下降2%，每股净收益从2023年的0.27美元降至2024年的0.09美元 [3] 分组3：诉讼指控内容 - 诉讼指控Zynex做出虚假和误导性陈述，未向投资者披露关键信息 [3] - 2024年6月4日，医学期刊STAAT报道称公司存在“过度供应计划”，向患者发送过多用品以增加账单金额，导致保险公司将其“踢出网络” [3] - 公司发货超过客户需求，虚增收入，其虚假索赔行为引起包括Tricare在内的保险公司审查，可能面临被移除保险网络和政府处罚等后果 [5] 分组4：调查相关 - Hagens Berman正在调查相关索赔，敦促有重大损失的投资者提交损失 [2] - 该公司合伙人Reed Kathrein表示关注Zynex的收入确认和销售实践潜在问题 [3] 分组5：公司信息 - Hagens Berman是全球原告权利复杂诉讼公司，专注企业问责，团队在此领域已获超29亿美元赔偿 [7] - 可在hbsslaw.com了解公司更多信息，关注@ClassActionLaw获取更新和新闻 [7]

ZYXI investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the l ...

NEW YORK, April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-f ...

On March 11, 2025, Zynex reported its fourth quarter and full year 2024 financial results, revealing a significant revenue "shortfall" in the quarter "due to slower than normal payments from certain payers." Zynex further revealed "Tricare has temporarily suspended payments as they review prior claims." Tricare is the health insurance program for the U.S. military. On this news, Zynex's stock price fell $3.59 per share, or 51.3%, to close at $3.41 per share on March 12, 2025. SAN DIEGO, March 31, 2025 /PRNe ...